PF-03463275 Uses, Dosage, Side Effects and more
PF-03463275 has been used in trials studying the treatment of Schizophrenia and Cognitive Impairments Associated With Schizophrenia.
| Attribute | Details |
|---|---|
| Trade Name | PF-03463275 |
| Generic | PF-03463275 |
| Type | |
| Formula | C19H22ClFN4O |
| Weight | Average: 376.86 Monoisotopic: 376.1466172 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
